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Pericardial diseases are rela­
tively common in clinical 
practice, presenting in one 
of three ways: pericarditis 
(which may recur or become 
chronic), pericardial effusion with or without 
peri cardial tamponade and constrictive 
peri carditis. Less common manifestations 
include pericardial cysts and neoplasms. A 
variety of aetiologies (Table 1) are implicated 
in peri cardial disease, and establishing a 
definitive diagnosis is challenging, as the 
yield of diag nostic tests is relatively low.[1] The 
incidence of acute pericarditis is 27.7/100 000 
cases in the developed world and accounts 
for 5% of emergency room admissions for 
chest pain.[2,3] Viral infection is responsible 
for the majority of cases in the developed 
world, while in the developing world Myco­
bacterium tuberculosis, particularly with HIV 
co­infection in sub­Saharan Africa, remains 
prevalent.[4,5] 
A paucity of randomised data exists in the 
field of pericardial disease; however, more 
recently multicentre randomised trials have 
defined the role of colchicine in acute and 
recurrent pericarditis and that of steroid 
therapy in tuberculous pericarditis.[6­8] This 
review focuses predominantly on an approach 
to acute pericarditis commonly encountered 
at primary care level, and offers brief insights 
into effusive disease and constriction.
An approach to 
pericarditis 
The following is a stepwise approach to 
acute pericarditis: 
• Presenting symptoms and signs. 
• Appropriate special investigations. 
• When to consider hospital admission.        
• Evidence­based medical therapy and assesss­
ing for a response. 
• Prognosis.
• Recurrent pericarditis.
Presenting symptoms and signs
Positional pleuritic chest pain, improved 
by sitting forward and exacerbated by deep 
inspi ration, is present in >85 ­ 90% of cases.[3] 
Radiation of pain to the trapezius ridge is 
virtually pathognomonic of pericarditis, 
as the phrenic nerve that innervates these 
muscles traverses the pericardium.[9] 
Prodromal symp toms of a viral illness may 
be present and constitutional symptoms 
of tuberculosis (TB) should be sought. 
Sinus tachycardia and low­grade fever 
are common, while a temperature >38oC 
suggests a specific cause of pericarditis. A 
triphasic pericardial friction rub is audible 
in approximately one­third of cases, best 
heard with the diaphragm of the stethoscope 
over the left lateral sternal border with the 
patient leaning forward (Audio 1).[3] This 
can be transient and frequent evaluation for 
its presence is useful as it is highly specific 
for the disease.
Signs of an underlying systemic inflam matory 
disease may point to a specific cause, e.g. systemic 
lupus erythematosus with a pericardial serositis.
A clinical diagnosis of pericarditis can be 
established when two of the following cri­
teria are present:[3]
• Pericarditic chest pain.
• Pericardial friction rub. 
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Table 1. Aetiology of pericardial disease
Infectious causes
Viral: coxsackieviruses, echoviruses, Epstein Barr virus, cytomegalovirus, parvovirus B19
Bacterial: TB, other bacterial causes are rare, e.g. Staphylococcus
Fungal: very rare, e.g. Candida species in immunocompromised patients
Parasitic: very rare, e.g. Echinococcus
Non-infectious causes
 Autoimmune: systemic lupus erythematosus, scleroderma, rheumatoid arthritis, 
Sjögren syndrome, acute rheumatic fever
 Neoplastic: primary tumours are rare; metastases from lung, breast and lymphoma are 
more common
Metabolic: renal failure, hypothyroidism
 Traumatic: early – penetrating or non­penetrating traumatic injury; 
delayed – postmyocardial infarction, post­cardiac surgery
Drug­induced: rare, e.g. hydralazine, all­trans retinoic acid 
 Other: sarcoidosis, aortic dissection (the pericardium includes the proximal 2 ­ 3 cm 
of the great vessels)
152       February 2016, Vol. 106, No. 2
CME




The following are recommended in all patients 
with suspected pericarditis: a 12­ lead ECG, a 
chest radiograph, inflam matory markers and 
a transthoracic echocardio gram.[10]
A 12-lead ECG is the first-line 
investigation
• Typical ECG findings are found in up to 
60% of patients, are highly variable between 
different patients and are influenced by 
therapy.[11]
• They include (Fig. 1):
• Widespread saddle­shaped (concave 
upward) ST­segment eleva tion not 
confined to a single coronary territory 
with reciprocal ST depression in aVR. 
• Inferior and precordial PR­segment 
depression with PR­segment elevation 
in aVR – the discordant ST­PR segment 
sign. This is more specific for pericarditis 
than diffuse ST elevation alone.[12] 
• Sinus tachycardia.
• Q waves may be present in post­myocardial 
infarction (MI) peri carditis. Both early and 
late (Dressler’s syndrome) manifest ations 
are rare in the era of reperfusion therapy; 
they may however occur after a silent MI 
or a missed infarct.
• Ultimately the ST and PR segments 
normalise, which may be followed by 
widespread T­wave inversion.
• The most important differential diagnosis 
is that of an ST­elevation acute coronary 
syndrome. This necessitates a thorough 
evaluation of the nature of the chest pain 
and the morphology and distribution of 
ST elevation on ECG.
Chest radiograph
• Features of pleuropulmonary disease may 
point to a specific aetiology, e.g. TB.[13]
• The cardiac silhouette only increases when 
>300 mL of pericardial fluid has collected 
and is therefore commonly normal in 
acute pericarditis.[14]
Laboratory tests
• Inflammatory markers: C­reactive protein 
(CRP), or erythrocyte sedimentation rate 
(ESR) where CRP is not available, and a 
white cell count should be undertaken 
in all cases. Elevations are supportive of 
a diagnosis of acute pericarditis and are 
valuable for monitoring disease activity 
and response to therapy.[15]
• Troponins may be elevated in patients with 
associated myocarditis.[16]
• Given its high prevalence in sub­Saharan 
Africa, TB should always be considered 
as a possible cause. Constitutional symp­
toms of TB and/or radiological evidence 
of the disease mandate further work­up. 
A high index of suspicion for TB must be 
maintained in patients from a disadvantaged 
socioeconomic setting.[17]
• Retroviral serology and serum creatinine 
level determination should be undertaken 
routinely.
• Routine serological markers for connective 
tissue disease are not indicated in low­risk 
cases; neither is routine viral serology as it has 
a low yield and does not alter manage ment.[1]
• A more detailed search for a specific cause 
is undertaken in patients requiring hospital 
admission or who fail a trial of medical therapy.
Transthoracic echocardiogram (TTE)
• An associated pericardial effusion, its 
haemodynamic effects and possible myo­
carditis can be evaluated via TTE.
• TTE is recommended in all patients.[10] 
However, in under­resourced areas it would 
not be unreasonable to limit it to patients 
requiring hospital admission or in whom a 
specific aetiology is suspected.
Cardiac magnetic resonance and cardiac 
computed tomography 
CMR can more accurately delineate pericardial 
inflammation by means of pericardial late 
gadolinium enhancement.[13] Cardiac CT also 
offers a more accurate assessment of peri­
cardial thickness than TTE, at the expense 
of exposure to ionising radiation. Neither 
of these adjunctive imaging modalities take 
preference over TTE as a first­line investigation. 
Their value is in the rare setting where a high 
clinical suspicion of pericarditis exists, yet the 
clinical diagnostic criteria remain unmet.[13]
When to consider hospital 
admission 
High-risk cases[18]
Hospital admission is required when a specific 
aetiology is suspected or when ≥1 of the 
following poor prognostic features are present:
• Temperature >38°C.
• Subacute onset.
• Large pericardial effusion (diastolic echo­




• Chronic oral anticoagulant or immuno­
suppressive therapy.
• Failure to respond to at least 1 week of 
aspirin or non­steroidal anti­inflam matory 
drug (NSAID) therapy.
A more detailed work­up, including evalua­
tion for TB, connective tissue disease and 
metabolic diseases, is required. When a 
specific cause is identified, therapy aimed at 
the underlying cause is indicated.
Evidence-based medical therapy 
and assessing for a response 
• Low­risk patients, in whom no specific 
cause is suspected and who do not have 
predictors of a poor prognosis, can be 
managed as outpatients.[10] It would not be 
unreason able to limit TTE in this group to 
those who fail to respond to 1 week of anti­
inflammatory therapy, particularly when 
managed at primary healthcare level.
• Restriction of physical activity is 
recommended until symptoms resolve and 
the CRP normalises. In athletes, a restrict­
ion of athletic activity for at least 3 months 
is advised, provided the CRP, ECG and 
TTE have returned to normal at the end of 
this period.[10] In suspected myopericarditis 
Fig. 1. A 12­lead ECG of a 29­year­old man with acute pericarditis. Sinus tachycardia, widespread 
saddle­shaped ST­segment elevation with PR­segment elevation in aVR and depression in the inferior 
and precordial leads V2 ­ V6 (the discordant ST­PR segment sign) are present.
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(elevated troponin level) athletic activity 
should be avoided for 6 months.[10]
• First­line medical therapy includes aspirin 
or NSAIDs and colchicine.[6,7] Gastro­
protection, preferably proton pump inhi­
bitors, should be provided (Table 2).
• Anti­inflammatory therapy commonly 
provides abrupt sympto matic relief.
• Colchicine, added to aspirin or NSAID 
therapy, has been evaluated in two well­
conducted, placebo­controlled, randomised 
clinical trials, where it has been shown to 
improve the response to medical therapy 
and prevent recurrences.[6,7] 
• Corticosteroids are associated with 
the evolution of acute pericarditis into 
a chronic, recurrent disease and are 
therefore not indicated as first­line 
therapy.[10] They are considered when 
NSAIDs or aspirin are contraindicated 
or have failed to provide a response, and 
an infective aetiology has been excluded. 
Alternatively, they are indicated when a 
specific cause mandates their use, such as 
connective tissue disease. When indicated 
for idiopathic disease, they should be used 
at a low­to­moderate dose together with 
colchicine and tapered once the CRP has 
normalised (Table 2).[10]
• Low­risk patients should be re­evaluated 
after 1 week for a response. Those who fail 
to respond (persistent symptoms and/or 
elevated CRP) are considered to be moderate 
risk and require hospital admission and 
an aetiology search. Those who respond 
infrequently require >2 weeks of NSAID or 
aspirin therapy, while colchicine should be 
continued for 3 months (Table 2).[10]
 Prognosis
• Acute idiopathic or viral pericarditis has a good 
prognosis with a low complication rate.[19] 
• Cardiac tamponade and constrictive 
pericarditis are more commonly asso­
ciated with specific underlying aetio lo­
gies, particu larly TB and purulent peri­
carditis.[19] 
• Up to 30% of idiopathic cases can develop 
recurrent pericarditis, associated with 
considerable morbidity.[20] This risk can be 
halved by the administration of colchicine 
at the outset.[20]
Recurrent pericarditis
• This is defined as a recurrence of peri carditis 
after a symptom­free period of 4 ­ 6 weeks 
after the initial illness. While up to 30% 
of patients may experience a recurrence 
after the index episode, the risk of a second 
recurrence may be as high as 50% in those 
not treated with colchicine, and even higher 
after corticosteroid administration.[20] 
• The most common cause for recurrent 
pericarditis is the inadequate treatment of 
an initial episode.[20] 
• A search for a potential underlying cause is 
required and referral for tertiary evaluation 
is recommended. 
• In cases of idiopathic disease, treatment is 
similar to that for a first attack, except for 
an extended duration of therapy with both 
NSAIDs (weeks ­ months) and weight­ad­
justed colchicine (≥6 months’ duration).[20]
• Corticosteroids remain second­line thera­
py owing to their risk for precipitating a 
chronic form of the disease. 
• In patients who do not respond to anti­
inflammatory therapy or who require high 
maintenance doses of prednisone, azathio­
prine, intravenous immunoglobulin and 
anakinra (a recombinant inter leukin 1β 
receptor antagonist) have been attempted.[10]
• As a last resort, after failed medical therapy, 
pericardiectomy may be required.[10]
• Overall, the prognosis is good in that a 
case of constrictive pericarditis has never 
been attributed to idiopathic recurrent 
pericarditis. However, morbidity is high 
owing to persistent symptoms.
An approach to 
pericardial effusions
• In sub­Saharan Africa TB is responsible 
in >90% of HIV­positive and 50 ­ 70% of 
HIV­negative patients who present with a 
large pericardial effusion. Emphasis must 
therefore be placed on excluding TB.[21]
• The development of cardiac tamponade, a 
life­threatening condi tion, is determined by 
the rate of fluid accumulation, pericardial 
compliance and position of a loculated 
collection. The rapid accumulation of 200 mL 
of fluid can lead to acute tamponade, whereas 
slow accumulation can be well tolerated 
owing to peri cardial distensibility.
• Loculated collections situated over low­
pressure chambers, e.g. the right ventricle, can 
result in early haemodynamic compromise.
• The 12­lead ECG may reveal small­voltage 
QRS complexes with electrical alternans 
due to swinging of the heart within a large 
collection (Fig. 2 and Video 1).
• Cardiac tamponade remains a clinical 
diagnosis. Clinical signs include:
• Tachycardia and elevated jugular venous 
pressure (JVP).
• Muffled heart sounds.
• Pulsus paradoxus (>10 mmHg inspira­
tory drop in systolic blood pressure).
• A TTE confirms the presence of an effusion, 
identifies the safest approach for needle 
aspiration and provides supportive evidence 
of associated haemodynamic compromise. 
Pericardiocentesis has a complication 
rate of 4 ­ 10%, depending on operator 
experience and procedural urgency.[22] 
Table 2. Recommended drug doses and durations for acute idiopathic pericarditis* 
Drug Dosing Duration Tapering
Aspirin 750 ­ 1 000 mg tds 1 ­ 2 weeks Decrease by 250 ­ 500 mg every 1 ­ 2 weeks
Ibuprofen 600 mg tds 1 ­ 2 weeks Decrease by 200 ­ 400 mg every 1 ­ 2 weeks
Colchicine <70 kg: 0.5 mg daily
≥70 kg: 0.5 mg bd
3 months Not mandatory 
Prednisone 0.2 ­ 0.5 mg/kg daily Tapered Slow taper, provided asymptomatic and 
CRP normal
*Combination therapy of colchicine with either aspirin or ibuprofen as initial therapy; steroids are second­line agents.
Fig. 2. A 12­lead ECG in a patient with a large pericardial effusion. Note the prominent electrical 
alternans.
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‘Blind’ pericardiocentesis is discouraged 
and TTE or ultrasonographic guidance to 
determine the site and angle of puncture 
is recommended.[22] In under­resourced 
areas, emergency pericardiocentesis in a 
haemodynamically unstable patient may 
be necessary without ultrasound guidance, 
provided the diagnosis of pericardial tampo­
nade is established as accurately as clinically 
possible. 
• Ultrasound or TTE availability is also 
useful for confirming a puncture that 
is within the pericardial space and not 
a cardiac chamber or pleural cavity by 
the injection of agitated contrast saline 
bubbles (Video 2).[23]
• All effusions should be evaluated for a 
specific underlying aetiology. If safely 
accessible, pericardiocentesis should be 
undertaken in a controlled environment 
by a skilled operator. 
• A pericardial fluid adenosine deaminase 
level ≥35 U/L has a sensitivity and speci­
ficity of 89% and 74%, respectively, for the 
diagnosis of TB pericarditis.[24] Traditional 
diagnostic tests for pericardial TB are 
insensitive and require long culture periods. 
The organism is not identified in the 
pericardial fluid of 27 ­ 48% of cases and 
adenosine deaminase therefore remains an 
important biochemical diag nostic aid.[24,25] 
• In our local experience complete percuta­
neous drainage of a tuberculous effusion, in 
combination with antituber culous therapy, 
is associated with an extremely low risk for 
constriction and cardiac death.[25] One 
small trial has shown that the addition of 
intrapericardial uro kinase may facilitate 
this approach.[26] The administration of 
intrapericardial steroids did not influence 
the risk of developing constriction in 
an underpowered trial of 57 patients.[27] 
However, more recently adjunc tive oral 
steroid therapy has been shown to reduce 
the risk of constriction in both HIV­positive 
and ­negative patients.[8] In this trial a 
definite diagnosis of TB pericarditis was 
established in 16.7% of participants. High­
dose oral prednisone did not translate into 
a mortality benefit and was unfortunately 
associated with an increase in HIV­related 
cancers in the HIV­positive group.[8] 
An approach to 
constrictive pericarditis
• Constriction is a form of diastolic heart 
failure that is potentially curable.
• The heart becomes encased in a rigid shell 
of pericardium, isolating it from the rest of 
the thoracic cavity. 
• Respiratory changes in intrathoracic pres­
sure can therefore not be transmitted to 
the heart, leading to the two hallmark 
physiological features of constriction:
• dissociation of intrathoracic and intra­
cardiac pressures; and
• enhanced ventricular interdependence 
(Fig. 3 A and B, and Video 3).
• Establishing a clinical diagnosis is challen­
ging and the disease therefore often goes 
unrecognised until late in its course, when 
overt right heart failure develops.
• A high index of suspicion is required in 
patients who have had prior TB, cardiac 
 Fig. 3. (A) The pulmonary veins lie extrapericardial. In health, changes in intrathoracic pressure are 
conveyed to both the pulmonary veins and the cardiac chambers (due to the compliant pericardium). 
On inspiration, negative intrathoracic pressure is exerted on both the pulmonary veins and the left 
ventricular (LV) cavity; this maintains the forward driving gradient over the mitral valve responsible 
for LV filling. In constriction, the heart is isolated from changes in intrathoracic pressure and therefore 
the transmitral forward driving gradient is degraded, with resultant slower filling of the LV compared 
with the right ventricle (RV) during inspiration.This image was taken during a left and right heart 
haemodynamic study of a patient with constrictive pericarditis. The light­blue line represents pulmonary 
capillary wedge pressure (a reflection of pulmonary venous pressure that varies with respiration), the 
red tracing represents intracavitary LV pressure (which does not vary with respiration in this isolated 
heart). Notice how the gradient (grey­shaded area) between the two is diminished during inspiration 
(white arrow), resulting in diminished inspiratory forward flow over the mitral valve. This represents the 
dissociation of intrathoracic and intracardiac pressures in constriction.
Fig. 3. (B) This image is from the same patient as in Fig. 3 (A). The light­blue trace represents RV pressure 
and the red trace LV pressure during tidal volume respiration. Notice how on inspiration (white arrow) the LV 
pressure falls (owing to relatively slower LV filling as a result of the dissociation of intrathoracic and intracardiac 
pressures) and the RV pressure consequently rises (in health the two should follow each other during respiration). 
This demonstrates the second physiological hallmark of constriction, i.e. enhanced ventricular interdependence.
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surgery, thoracic irradiation or pericarditis. TB remains the most 
important cause in South Africa.[8]
• Symptoms range from a change in effort tolerance to those of
predominant right heart failure.
• Clinical signs may be subtle and careful evaluation for their
presence is required:
• A raised JVP with rapid y­descents (Video 4). The JVP may be
raised to a point within the cranium at a recumbent level of 45° 
and may therefore not be visible. The level of elevation often
only becomes apparent in the upright position.
• Kussmaul’s sign – paradoxical inspira tory elevation of the JVP.
• Diastolic apex beat.
• A right ventricular pericardial knock (Audio 2).
• Ascites that is more prominent than the degree of peripheral
oedema.
• A lateral chest radiograph can reveal pericardial calcification in up 
to 50% of patients with tuberculous constriction (Fig. 4).
• The clinical diagnosis can be confirmed by TTE, with tissue
Doppler imaging aiding in both establishing the diagnosis and
differentiating constriction from restrictive cardiomyopathy.
An invasive left and right heart study is infrequently required,
but is most useful to distinguish constriction from restrictive
cardiomyopathy if doubt exists despite a detailed TTE.
• Early diagnosis leads to timelier referral for surgical
pericardiectomy, thereby reducing perioperative mortality. This
risk is as high as 15% in patients who already have a New York
Heart Association class IV effort tolerance and/or hyponatraemia
at the time of surgery.[28] 
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Audiofiles (headphones are required) and videoclips
Audio 1. Typical triphasic pericardial rub recorded in a patient with acute pericarditis. 
Audio 2. Recording of a pericardial knock in a patient with constrictive pericarditis. The early 
diastolic knock is heard just after the second heart sound over the left sternal border, occurring earlier 
in diastole than an S3.
Video 1. Apical 4­chamber TTE image of a patient with a large pericardial effusion. Note the 
electrical alternans on the recorded ECG strip. As the heart swings to and fro within the fluid, the 
direction of the main vector of depolarisation changes from beat to beat, producing the ECG 
finding of electrical alternans.
Video 2. Pericardiocentesis in the emergency room. Before a 6­French sheath or central venous pressure 
line is inserted, the puncture needle is held in place and agitated saline bubble contrast injected to confirm 
one’s position. Note the echobright saline bubbles within the pericardial space, which confirms that the 
operator has punctured the pericardial space and can safely proceed with the aspiration procedure.
Video 3. Apical 4­chamber TTE image (RV on left of image, LV on the right) in the same patient as 
in Fig. 3A and B. Note the simultaneous respirometer trace and bi­atrial dilatation. During 
inspiration the RV fills relatively more quickly than the LV owing to the degraded transmitral 
forward driving gradient. The result is respiratophasic septal shift into the LV.
Video 4. Rapid y­descents seen in the JVP of a patient with constrictive pericarditis. These are 
generally appreciated as rapid inward ‘flicking’ movements in the presence of an elevated JVP (courtesy 
Dr Annari van Rensburg).
Fig. 4. Lateral chest radiograph. Calcification commonly occurs over the RV, 
diaphragmatic surface and apex (the latter two are visible on this film). The 
chest radiograph, often forgotten, is an inexpensive adjunct to establishing 
the diagnosis of constrictive pericarditis. 
